HomeOracleCVE-2026-21980

CVE-2026-21980

MEDIUM
6.5CVSS
Published: 2026-01-20
Updated: 2026-01-29
AI Analysis

Description

Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

CVSS Metrics

Vector
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
Attack Vector
network
Complexity
low
Privileges
none
User Action
none
Scope
unchanged
Confidentiality
low
Integrity
low
Availability
none
Weaknesses
NVD-CWE-noinfo

Metadata

Primary Vendor
ORACLE
Published
1/20/2026
Last Modified
1/29/2026
Source
NIST NVD
Note: Verify all details with official vendor sources before applying patches.

Affected Products

oracle : life_sciences_central_coding

AI-Powered Remediation

Generate remediation guidance or a C-suite brief for this vulnerability.

Executive Intelligence Brief